Stigma attached to medication overuse headache from the healthcare professional perspective

At EAN 2022, Dr Henrik Schytz, discussed how there is not a lot of stigma attached to medication overuse headache (MOH) from the healthcare professional (HCP) perspective. MOH may be challenging for HCPs as ‘treatment’ involves stopping pain-relieving medication, which they may view as wrong. Patients with MOH need to be followed up as once the causative medication is stopped, they may return to it and new ways might be needed to help them. In some countries, preventative medication is indicated at the time of withdrawal of acute medication, which, Dr Schytz proposed, may relieve the HCP of feeling they are not treating their patient.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country